Revised SPC: Zyban (bupropion hydrochloride) 150 mg prolonged release tablets
SPC updated to include aggravation of Systemic lupus erythematosus syndrome and cutaneous lupus erythematosus as undesirable effects of unknown frequency.
Source:
electronic Medicines compendium